Carna Biosciences, Inc.
Records under this name other than the patents Carna Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Showing 1 to 5 of 5 · Back to Carna Biosciences, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,682,961 | Novel Quinazoline Derivative Formerly held Lapsed on the fee record Ended Jun 20, 2025 · High confidence | Lapsed on the fee record | Ended Jun 20, 2025 | High confidence |
| US 10,538,521 | Pyrimidine derivative having antimalarial activity Lapsed on the fee record Ended Jan 21, 2024 · USPTO record | Lapsed on the fee record | Ended Jan 21, 2024 | USPTO record |
| US 9,102,637 | Novel Bicyclic Thiazole Compounds Lapsed on the fee record Ended Aug 11, 2023 · Medium confidence | Lapsed on the fee record | Ended Aug 11, 2023 | Medium confidence |
| US 8,742,113 | Furanone derivative Surrendered on reissue Surrendered on reissue May 1, 2018 · USPTO record | Surrendered on reissue | Surrendered on reissue May 1, 2018 | USPTO record |
| US 7,223,779 | Azasugar derivative and drug containing the same as the active ingredient Lapsed on the fee record Ended May 29, 2011 · USPTO record | Lapsed on the fee record | Ended May 29, 2011 | USPTO record |